Wald A - Search Results

1

Using plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission.

Murnane PM, Hughes JP, Celum C, Lingappa JR, Mugo N, Farquhar C, Kiarie J, Wald A, Baeten JM; Partners in Prevention HSV/HIV Transmission Study Team. Murnane PM, et al. Among authors: wald a. PLoS One. 2012;7(11):e51192. doi: 10.1371/journal.pone.0051192. Epub 2012 Nov 30. PLoS One. 2012. PMID: 23250272 Free PMC article. Clinical Trial.

2

Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.

Wald A, Zeh J, Barnum G, Davis LG, Corey L. Wald A, et al. Ann Intern Med. 1996 Jan 1;124(1 Pt 1):8-15. doi: 10.7326/0003-4819-124-1_part_1-199601010-00002. Ann Intern Med. 1996. PMID: 7503497 Clinical Trial.

3

Virologic characteristics of subclinical and symptomatic genital herpes infections.

Wald A, Zeh J, Selke S, Ashley RL, Corey L. Wald A, et al. N Engl J Med. 1995 Sep 21;333(12):770-5. doi: 10.1056/NEJM199509213331205. N Engl J Med. 1995. PMID: 7643884 Free article.

4

Seroprevalence of herpes simplex virus infections in a family medicine clinic.

Oliver L, Wald A, Kim M, Zeh J, Selke S, Ashley R, Corey L. Oliver L, et al. Among authors: wald a. Arch Fam Med. 1995 Mar;4(3):228-32. doi: 10.1001/archfami.4.3.228. Arch Fam Med. 1995. PMID: 7881604

5

Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic responses after genital HSV-2 infection.

Ashley R, Wald A, Corey L. Ashley R, et al. Among authors: wald a. J Virol. 1994 Aug;68(8):5284-6. doi: 10.1128/JVI.68.8.5284-5286.1994. J Virol. 1994. PMID: 8035526 Free PMC article.

6

A randomized, double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first-episode genital herpes infections.

Wald A, Benedetti J, Davis G, Remington M, Winter C, Corey L. Wald A, et al. Antimicrob Agents Chemother. 1994 Feb;38(2):174-6. doi: 10.1128/AAC.38.2.174. Antimicrob Agents Chemother. 1994. PMID: 8192438 Free PMC article. Clinical Trial.

7

Influence of HIV infection on manifestations and natural history of other sexually transmitted diseases.

Wald A, Corey L, Handsfield HH, Holmes KK. Wald A, et al. Annu Rev Public Health. 1993;14:19-42. doi: 10.1146/annurev.pu.14.050193.000315. Annu Rev Public Health. 1993. PMID: 8323586 Review. No abstract available.

8

Subclinical shedding of HSV: its potential for reduction by antiviral therapy.

Corey L, Wald A, Davis LG. Corey L, et al. Among authors: wald a. Adv Exp Med Biol. 1996;394:11-6. doi: 10.1007/978-1-4757-9209-6_2. Adv Exp Med Biol. 1996. PMID: 8815678 Review. No abstract available.

9

Evaluation of a quantitative competitive PCR assay for measuring herpes simplex virus DNA content in genital tract secretions.

Hobson A, Wald A, Wright N, Corey L. Hobson A, et al. Among authors: wald a. J Clin Microbiol. 1997 Mar;35(3):548-52. doi: 10.1128/jcm.35.3.548-552.1997. J Clin Microbiol. 1997. PMID: 9041386 Free PMC article.

10

Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.

Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Wald A, et al. J Clin Invest. 1997 Mar 1;99(5):1092-7. doi: 10.1172/JCI119237. J Clin Invest. 1997. PMID: 9062368 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

803 results

Search Page

Filters